These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15379645)

  • 21. Virtual darwinian drug design: QSAR inverse problem, virtual combinatorial chemistry, and computational screening.
    de Julian-Ortiz JV
    Comb Chem High Throughput Screen; 2001 May; 4(3):295-310. PubMed ID: 11375744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of virtual compound screening.
    Heikamp K; Bajorath J
    Chem Biol Drug Des; 2013 Jan; 81(1):33-40. PubMed ID: 23253129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtual compound screening in drug discovery.
    Stumpfe D; Ripphausen P; Bajorath J
    Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docking and scoring in virtual screening for drug discovery: methods and applications.
    Kitchen DB; Decornez H; Furr JR; Bajorath J
    Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual screening and fast automated docking methods.
    Schneider G; Böhm HJ
    Drug Discov Today; 2002 Jan; 7(1):64-70. PubMed ID: 11790605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of mathematical structural invariants in analyzing combinatorial libraries: a case study with psoralen derivatives.
    Basak SC; Mills D; Gute BD; Balaban AT; Basak K; Grunwald GD
    Curr Comput Aided Drug Des; 2010 Dec; 6(4):240-51. PubMed ID: 20883202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-directed combinatorial library design.
    Zhou JZ
    Curr Opin Chem Biol; 2008 Jun; 12(3):379-85. PubMed ID: 18328830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinatorial chemistry in glycobiology.
    Plante OJ
    Comb Chem High Throughput Screen; 2005 Mar; 8(2):153-9. PubMed ID: 15777179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of neural networks to large dataset QSAR, virtual screening, and library design.
    Winkler DA; Burden FR
    Methods Mol Biol; 2002; 201():325-67. PubMed ID: 12357937
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of new potent GPR119 agonists by combining virtual screening and combinatorial chemistry.
    Wellenzohn B; Lessel U; Beller A; Isambert T; Hoenke C; Nosse B
    J Med Chem; 2012 Dec; 55(24):11031-41. PubMed ID: 23211099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the chemogenomic knowledge space with annotated chemical libraries.
    Savchuk NP; Balakin KV; Tkachenko SE
    Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of 'drug-likeness'.
    Walters WP; Murcko MA
    Adv Drug Deliv Rev; 2002 Mar; 54(3):255-71. PubMed ID: 11922947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening: an effective tool for lead structure discovery?
    Langer T; Hoffmann RD
    Curr Pharm Des; 2001 May; 7(7):509-27. PubMed ID: 11375766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
    Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of virtual combinatorial libraries.
    Aronov AM
    Methods Mol Biol; 2002; 201():267-76. PubMed ID: 12357932
    [No Abstract]   [Full Text] [Related]  

  • 38. Diverse viewpoints on computational aspects of molecular diversity.
    Martin YC
    J Comb Chem; 2001; 3(3):231-50. PubMed ID: 11350246
    [No Abstract]   [Full Text] [Related]  

  • 39. Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.
    Hevener KE
    Methods Mol Biol; 2018; 1800():275-285. PubMed ID: 29934898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of virtual screening into the drug discovery process.
    Chin DN; Chuaqui CE; Singh J
    Mini Rev Med Chem; 2004 Dec; 4(10):1053-65. PubMed ID: 15579113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.